Chi-Joan How, MD, named Clinical Chief of Hematology

Chi-Joan “Joan” How, MD, has been named Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital.

Dr. How studied neurobiology as an undergraduate at Harvard College before attending medical school at the Yale School of Medicine. She completed her internship and residency in medicine at Barnes Jewish Hospital, Washington University in St. Louis and the CSTAR: Clinical Scientist Training and Research Program also at Washington University. She completed a clinical fellowship in Hematology/Oncology at Dana-Farber Cancer Institute, Harvard Medical School. Since August of 2021, she has served as an associate physician in the Brigham and Women’s Division of Hematology seeing patients here on the BWFH campus. Dr. How has a clinical and research interest in myeloproliferative neoplasms.

In her role as Clinical Chief of Hematology, Dr. How will provide the overall medical and administrative direction to the BWFH Hematology group. Her responsibilities will include organizing clinical schedules for the inpatient consult service and ambulatory clinics. She will work closely with the Division leadership to ensure the BWFH group delivers outstanding patient care, an exceptional educational experience for trainees, and a forum for clinical research in hematology. She will also participate in planning and implementation of strategic initiatives.

Of her decision to take on this new challenge, she says, “I’ve really enjoyed working at BWFH and am eager to take on a new leadership role that will enhance patient care and all our hematology initiatives.”

When it comes to life outside of work, Dr. How says, “When I’m not busy keeping my toddler in check, I love to read! I’m a huge bibliophile so if you ever need a book recommendation, just let me know.”

Published 1/5/23

Read more news from Brigham and Women's Faulkner Hospital

Looking for more news from BWFH? Go to News to find articles about health, updates to our programs and services and stories about staff and patients.

Go to News